SELLAS Life Sciences Group, Inc.SLSNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank71
5Y CAGR-7.6%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
-7.6%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 10.28% |
| 2024 | 16.78% |
| 2023 | 9.73% |
| 2022 | -65.85% |
| 2021 | -48.95% |
| 2020 | 15.26% |
| 2019 | 36.56% |
| 2018 | -101.02% |
| 2017 | 1.71% |
| 2016 | 53.28% |